Themis Medicare Limited

NSE THEMISMED.NS

Themis Medicare Limited Price to Earnings Ratio (P/E) on February 06, 2025: 48.02

Themis Medicare Limited Price to Earnings Ratio (P/E) is 48.02 on February 06, 2025, a 31.02% change year over year. Price to earnings ratio compares the stock price to earnings per share; higher P/E suggests expectations for future earnings growth.

Themis Medicare Limited 52-week high Price to Earnings Ratio (P/E) is 62.47 on December 02, 2024, which is 30.10% above the current Price to Earnings Ratio (P/E).
Themis Medicare Limited 52-week low Price to Earnings Ratio (P/E) is 31.90 on February 12, 2024, which is -33.56% below the current Price to Earnings Ratio (P/E).
Themis Medicare Limited average Price to Earnings Ratio (P/E) for the last 52 weeks is 49.51.

Key data

Date	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)	Dividend Yield

NSE: THEMISMED.NS

Themis Medicare Limited

CEO	Dr. Sachin Dinesh Patel CChem., Ph.D.
IPO Date	April 2, 2007
Location	India
Headquarters	11/12 Udyog Nagar Industrial Estate
Employees	1,509
Sector	Healthcare
Industries Pharmaceuticals Biotechnology Chemicals & Advanced Materials Cosmetics Drugstores & Retail Pharmacies Eyewear Personal Care

Description

Themis Medicare Limited, together with its subsidiaries, manufactures and sells pharmaceutical products in India and internationally. It offers active pharmaceutical ingredients and formulations for use in various therapeutic areas, including anti-infective, antimalarial, anti-tuberculosis, cardiology, health and nutrition, oncology, ophthalmology, and pain management. The company was formerly known as Themis Chemicals and changed its name to Themis Medicare Limited in 2001. Themis Medicare Limited was incorporated in 1969 and is headquartered in Mumbai, India.

Key trends

Past 5 years